Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease
- PMID: 16457710
- PMCID: PMC1382277
- DOI: 10.1186/1476-7120-4-9
Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease
Abstract
Background: Though hemodialysis (HD) acutely improves cardiac function, the impact of background diseases like coronary artery disease (CAD) and Type 2 diabetes (DM) in the setting of end-stage renal disease (ESRD) is not known. Tissue velocity echocardiography (TVE) offers a fast choice to follow changes in myocardial function after HD in ESRD with concomitant DM and /or CAD.
Methods: 46 subjects (17 with ESRD, Group 1; 15 with DM, Group 2; 14 with DM+CAD, Group 3) underwent standard and TVE prior to and shortly after HD. Besides standard Doppler variables, regional myocardial systolic and diastolic velocities, as well as systolic strain rate were post processed.
Results: Compared with pre-HD, post-HD body weight (kg) significantly decreased in all the three groups (51 +/- 9 vs. 48 +/- 8, 62 +/- 10 vs.59 +/- 10, and 61 +/- 9 vs. 58 +/- 9 respectively; all p < 0.01). Left ventricular end diastolic dimensions (mm) also decreased post- HD (46 +/- 5 vs. 42 +/- 7, 53 +/- 7 vs. 50 +/- 7, 51 +/- 7 vs. 47 +/- 8 respectively; all p < 0.01). Regional longitudinal peak systolic velocity in septum (cm/s) significantly increased post-HD in Group 1(5.7 +/- 1.6 vs. 7.2 +/- 2.3; p < 0.001) while remained unchanged in the other two groups. Similar trends were noted in other left ventricular walls. When the myocardial velocities (cm/s) were computed globally, the improvement was seen only in Group 1 (6.3 +/- 1.5 vs. 7.9 +/- 2.0; p < 0.001). Global early regional diastolic velocity (cm/s) improved in Group 1, remained unchanged in Group 2, while significantly decreased in Group 3(-5.9 +/- 1.3 vs. -4.1 +/- 1.8; p < 0.01). Global systolic strain rate (1/sec) increased in the first 2 Groups but remained unchanged (-0.87 +/- 0.4 vs. -0.94 +/- 0.3; p = ns) in Group 3.
Conclusion: A single HD session improves LV function only in ESRD without coexistent DM and/or CAD. The present data suggest that not only dialysis-dependent changes in loading conditions but also co-existent background diseases determine the myocardial response to HD.
Figures



Similar articles
-
Acute effects of hemodialysis on left ventricular function evaluated by tissue Doppler imaging.Biomed Pharmacother. 2006 Feb;60(2):66-70. doi: 10.1016/j.biopha.2005.10.008. Epub 2005 Dec 28. Biomed Pharmacother. 2006. PMID: 16459054 Clinical Trial.
-
Load-independent parameters of diastolic and systolic function by speckle tracking and tissue doppler in hemodialysis patients.Rev Port Cardiol. 2008 Sep;27(9):1011-25. Rev Port Cardiol. 2008. PMID: 19044173 English, Portuguese.
-
Role of haemodialytic therapy on left ventricular mechanical dyssynchrony in patients with end-stage renal disease quantified by speckle-tracking strain imaging.Nephrol Dial Transplant. 2011 May;26(5):1655-61. doi: 10.1093/ndt/gfq590. Epub 2010 Sep 23. Nephrol Dial Transplant. 2011. PMID: 20864553
-
Hemodialysis does not impair ventricular functions over 2 years.Hemodial Int. 2011 Jul;15(3):334-40. doi: 10.1111/j.1542-4758.2011.00549.x. Epub 2011 Apr 20. Hemodial Int. 2011. PMID: 21507196 Clinical Trial.
-
Hemodialysis improves myocardial interstitial edema and left ventricular diastolic function in patients with end-stage renal disease: noninvasive assessment by ultrasonic tissue characterization.Heart Vessels. 2002 Sep;16(6):227-31. doi: 10.1007/s003800200029. Heart Vessels. 2002. PMID: 12382031
Cited by
-
Left ventricular strain and peak systolic velocity: responses to controlled changes in load and contractility, explored in a porcine model.Cardiovasc Ultrasound. 2012 May 28;10:22. doi: 10.1186/1476-7120-10-22. Cardiovasc Ultrasound. 2012. PMID: 22640913 Free PMC article.
-
Incremental value of global longitudinal strain in prediction of all-cause mortality in predialysis and dialysis chronic kidney disease patients.Wien Klin Wochenschr. 2016 Jul;128(13-14):495-503. doi: 10.1007/s00508-016-0978-9. Epub 2016 Mar 14. Wien Klin Wochenschr. 2016. PMID: 26975452 Clinical Trial.
References
-
- American Diabetes Association Position Statement Nephropathy in Diabetes. Diabetes Care. 2004;27:79S–83S.
-
- Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;200:1134–46. - PubMed
-
- Eknoyan G. On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes. Am J Kidney Dis. 1998;32:S1–S4. - PubMed
-
- Foley RN, Parfrey PS, Sarnak MJ. Clinical Epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112–S119. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous